The Implementation of Pre-exposure Prophylaxis of Injectable Cabotegravir — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The Implementation of Pre-exposure Prophylaxis of Injectable Cabotegravir — Stella

Recruiting

Back to HIV Infections trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

Brazil

Instituto Nacional de Infectologia Evandro Chagas/ FIOCRUZ, Rio de Janeiro

Key details

Phase

Large-scale testing

Sponsor

Evandro Chagas National Institute of Infectious Disease

Collaborators

Beatriz Grinsztejn, Thiago Torres

Enrollment target

~1,200 participants

Started

September 2022

Primary completion

October 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 30 Years

Sex

Male only

Last updated October 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov